| April 2025 | AACR (American Association of Cancer Research) Annual meeting | "ON" state pan-KRAS direct inhibitors | KRAS | Read More | 
        
            | Feb 2023 | Scientific Reports | Alleviation of arthritis through prevention of neutrophil extracellular traps by an orally available inhibitor of protein arginine deiminase 4 | PAD4 | Read More | 
        
            | Jan 2023 | PLOS ONE | Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer | Dual LSD1/HDAC6 | Read More | 
        
            | Nov 2022 | Society for Immunotherapy of Cancer’s (SITC) | Novel, brain penetrant small molecule inhibitor of PD-L1 for targeting glioblastoma and brain metastasis | PD-L1 | Read More | 
        
            | Nov 2022 | Society for Immunotherapy of Cancer’s (SITC) | Novel, gut-restricted small molecule inhibitor of PD-L1 for targeting GI cancers | PD-L1 | Read More | 
        
            | Nov 2022 | EORTC | Novel, brain penetrant small molecule inhibitor of PD-L1 for targeting glioblastoma and brain metastasis | PD-L1 | Read More | 
        
            | Sep 2022 | Cancer Research | Regulation of tumor progression by PAD4-mediated neutrophil migration and its targeting with a novel selective inhibitor JBI-589 | PAD4 | Read More | 
        
            | June 2022 | American Society of Clinical Oncology (ASCO) Annual Meeting | Novel brain penetrant inhibitors of PD-L1 | PD-L1 | Read More | 
        
            | April 2022 | AACR (American Association of Cancer Research) Annual meeting | Novel, selective PAD4 inhibitor for treatment of cancer | PAD4 | Read More | 
        
            | April 2021 | AACR (American Association of Cancer Research) Annual meeting | Novel, small molecule PRMT5 Inhibitors for treatment of cancer | PRMT5 | Read More | 
        
            | April 2021 | AACR (American Association of Cancer Research) Annual meeting | Novel, heterocyclic small molecule inhibitors of PD-1/PD-L1 pathway | PD-L1 | Read More | 
        
            | Dec 2020 | Bioorg Med Chem Lett. 2020 Dec 24;34:127763 | Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma | Dual LSD1/HDAC6 | Read More | 
        
            | Dec 2020 | The 62nd ASH (American Society oh Hematology) Annual Meeting and Exposition | JBI-802: Novel LSD1/HDAC6 inhibitor with a unique mechanism of action | Dual LSD1/HDAC6 | Read More | 
        
            | April 2020 | AACR (American Association of Cancer Research) Annual meeting | Novel dual small molecule inhibitor targeting LSD1/HDAC6/8 | Dual LSD1/HDAC6 | Read More | 
        
            | Nov 2019 | ACR (American College of Rheumatology)/ARP Annual Meeting | Novel PAD4 inhibitors for the treatment of autoimmune disorders | PAD4 | Read More | 
        
            | April 2019 | AACR (American Association of Cancer Research) Annual meeting | Novel dual small molecule inhibitor targeting LSD1/HDAC6/8 | Dual LSD1/HDAC6 | Read More |